功能神经影像区分神经病理性疼痛药物机制与安慰剂效应
该双盲随机安慰剂对照三交叉试验在16例创伤后神经病理性疼痛患者中长期服用普瑞巴林或曲马多,用3T MRI测量主观疼痛、触诱发痛相关神经活动及静息态功能连接。结果显示普瑞巴林较安慰剂显著抑制触诱发痛相关神经活动但无行为镇痛,安慰剂显著增加前扣带吻侧与脑干功能连接。
要点
- 普瑞巴林可抑制触诱发痛相关脑区神经活动,但不产生行为镇痛。
- 安慰剂增加前扣带吻侧与脑干功能连接,支持安慰剂镇痛神经机制。
- 功能神经影像可在概念验证阶段提供药物效力的客观证据。
核心结论
- 功能神经影像在主观疼痛指标不可靠时提供药物效力的客观证据。
- 安慰剂臂证实临床试验患者中安慰剂镇痛的神经机制。
研究设计与样本
- 双盲、随机、安慰剂对照、三交叉试验,16例创伤后神经病理性疼痛患者。
- 长期服用普瑞巴林或曲马多,3T MRI采集主观疼痛、触诱发痛神经活动及静息态功能连接。
- 基线静息态数据在洗脱现有药物后采集。
主要发现
- 与安慰剂相比,普瑞巴林显著抑制多个伤害性感受和疼痛处理脑区的触诱发痛相关神经活动,但无行为镇痛。
- 安慰剂显著增加前扣带吻侧与脑干之间的功能连接。
临床怎么用
- 在早期概念验证研究中,可用功能神经影像作为药物效力的客观补充指标。
- 解读镇痛试验结果时需考虑安慰剂效应对神经功能连接的影响。
局限性
- 样本量小(16例),结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A lack of objective outcome measures and overreliance on subjective pain reports in early proof-of-concept studies contribute to the high attrition of potentially effective new analgesics. We studied the utility of neuroimaging in providing objective evidence of neural activity related to drug modulation or a placebo effect in a double-blind, randomized, placebo-controlled, three-way crossover trial. METHODS: We chronically administered pregabalin or tramadol (first-line and second-line analgesics, respectively), recommended for neuropathic pain, in 16 post-traumatic neuropathic pain patients. We measured subjective pain reports, allodynia-evoked neural activity, and brain resting state functional connectivity from patients during the three sessions and resting state data at baseline from patients after washout of their current medication. All data were collected using a 3 T MRI scanner. RESULTS: When compared with placebo only, pregabalin significantly suppressed allodynia-evoked neural activity in several nociceptive and pain-processing areas of the brain, despite the absence of behavioural analgesia. Furthermore, placebo significantly increased functional connectivity between the rostral anterior cingulate and the brainstem, a core component of the placebo neural network. CONCLUSIONS: Functional neuroimaging provided objective evidence of pharmacodynamic efficacy in a proof-of-concept study setting where subjective pain outcome measures are often unreliable. Additionally, we provide evidence confirming the neural mechanism underpinning placebo analgesia as identified in acute experimental imaging studies in patients during the placebo arm of a clinical trial. We explore how brain penetrant active drugs potentially interact with this mechanism. CLINICAL TRIAL REGISTRATION: NCT0061015.
引用
- Wanigasekera V, Wartolowska K, Huggins JP, et al. Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging. Br J Anaesth. 2017. PMID: 29406179. doi:10.1016/j.bja.2017.11.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。